Home / Allopurinol / United States
US ATC M04AA01 · updated 2 Nov 2026
Allopurinol shortage in United States
Is there an Allopurinol shortage in United States?
Yes. As of 2 Nov 2026, 4 Allopurinol products are reported short in United States, the first since 19 Feb 2026. No return date has been given. Main reason: not stated.
Also short in Italy, Spain, Ireland, Austria, Belgium, Czechia, Sweden, Japan. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Allopurinol, Tablet, 100 mg (NDC 0591-5543-01) discontinuation | Teva Pharmaceuticals USA, Inc. | 19 Feb 2026 | not given | Not stated |
| US | Allopurinol, Tablet, 100 mg (NDC 0591-5543-10) discontinuation | Teva Pharmaceuticals USA, Inc. | 19 Feb 2026 | not given | Not stated |
| US | Allopurinol, Tablet, 300 mg (NDC 0591-5544-01) discontinuation | Teva Pharmaceuticals USA, Inc. | 19 Feb 2026 | not given | Not stated |
| US | Allopurinol, Tablet, 300 mg (NDC 0591-5544-05) discontinuation | Teva Pharmaceuticals USA, Inc. | 19 Feb 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).